Michael Parini Vertex Pharmaceuticals Inc (VRTX) insider trading activity

Michael Parini is EVP, Chief Adm, Leg & BD Off of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 30,837 shares of VRTX, which is worth approximately $15 Million. The most recent transaction as insider was on Feb 25, 2021, when has been sold 3,028 shares (Common Stock) at a price of $213.79 per share, resulting in proceeds of $647,356. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.8K

0% 3M change

0% 12M change

Total Value Held $15 Million

Michael Parini Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 25 2021	SELL Open market or private sale	$647,356 $213.79 p/Share	3,028 Reduced 8.94%	30,837 Common Stock
Feb 24 2021	SELL Payment of exercise price or tax liability	$525,649 $217.57 p/Share	2,416 Reduced 6.66%	33,865 Common Stock
Feb 18 2021	SELL Open market or private sale	$1,658,743 $211.98 p/Share	7,825 Reduced 17.74%	36,281 Common Stock
Feb 17 2021	SELL Payment of exercise price or tax liability	$1,321,320 $211.75 p/Share	6,240 Reduced 12.39%	44,106 Common Stock
Feb 11 2021	SELL Open market or private sale	$911,962 $211.2 p/Share	4,318 Reduced 7.9%	50,346 Common Stock
Feb 10 2021	SELL Payment of exercise price or tax liability	$548,892 $214.16 p/Share	2,563 Reduced 4.48%	54,664 Common Stock
Feb 05 2021	SELL Open market or private sale	$414,950 $215.0 p/Share	1,930 Reduced 3.26%	57,227 Common Stock
Feb 05 2021	BUY Exercise of conversion of derivative security	$166,984 $86.52 p/Share	1,930 Added 3.16%	59,157 Common Stock
Feb 03 2021	SELL Open market or private sale	$86,764 $216.91 p/Share	400 Reduced 0.69%	57,227 Common Stock
Feb 03 2021	BUY Exercise of conversion of derivative security	$34,608 $86.52 p/Share	400 Added 0.69%	57,627 Common Stock
Feb 03 2021	BUY Grant, award, or other acquisition	-	30,389 Added 34.68%	57,227 Common Stock
Nov 16 2020	SELL Open market or private sale	$20,339 $223.51 p/Share	91 Reduced 0.34%	26,838 Common Stock
Nov 04 2020	SELL Open market or private sale	$509,035 $218.47 p/Share	2,330 Reduced 7.99%	26,838 Common Stock
Nov 04 2020	BUY Exercise of conversion of derivative security	$201,592 $86.52 p/Share	2,330 Added 7.4%	29,168 Common Stock

Michael Parini

EVP, Chief Adm, Leg & BD Off

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Vertex Pharmaceuticals Inc insider buys or sells VRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to VERTEX PHARMACEUTICALS INC

Track Activities on VRTX

Account